StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Argus on Zimmer Biomet (ZBH): 'this as an attractive valuation'
March 30, 2026 7:27 AM
Argus analyst David Toung reiterated a Buy rating and $125.00 price target on Zimmer Biomet (NYSE: ZBH).The analyst comments "Restructuring ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
